Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI)

The Maximizing Investigators Research Award for Early Stage Investigators is offered by the National Institute of General Medical Sciences, which is part of the National Institutes of Health within the U.S. Department of Health and Human Services. NIGMS is a federal agency that supports fundamental biomedical research aimed at understanding biological processes and advancing scientific knowledge. This funding opportunity is designed specifically to empower early stage investigators by providing stable, long-term support to establish and sustain independent research programs that align with the NIGMS mission. The purpose of this program is to enhance the productivity and career development of early stage investigators by funding a broad, flexible program of research rather than a single project. The award encourages investigators to pursue ambitious, creative, and potentially transformative research while maintaining the flexibility to adapt to new scientific directions. The program emphasizes supporting a wide range of investigators and institutions across the United States to increase diversity in scientific inquiry and improve the likelihood of major breakthroughs. Funding is provided as a grant with a project period of up to five years, divided into annual budget periods. Applicants may request up to 275000 dollars in direct costs per year. The award supports research activities that fall within the NIGMS mission, including basic biomedical research, technology development, computational approaches, and certain clinical research areas such as anesthesiology, pharmacology, and systemic inflammatory responses. However, the program does not allow subawards, large-scale clinical trials focused on safety and efficacy, or research outside the NIGMS mission. There is no cost-sharing or matching requirement for this opportunity. Eligibility is limited to organizations such as institutions of higher education, nonprofits, for-profit organizations, and government entities, provided they are based in the United States. Foreign institutions are not eligible to apply, although limited foreign components may be included if they do not require NIH funding. The principal investigator must qualify as an NIH-defined Early Stage Investigator and must commit at least 51 percent of their research effort to the award. Only single principal investigator applications are permitted. Applications must be submitted through Grants.gov using approved systems such as ASSIST or institutional submission platforms. Applicants must complete registrations in SAM.gov, Grants.gov, and eRA Commons prior to submission. Required components include standard federal grant forms, a research plan, a biographical sketch, budget information, and a mandatory institutional commitment letter. Notably, applicants are prohibited from including specific aims sections and must instead provide a broad overview of their research program and future directions. Applications are evaluated through the NIH peer review process based on scientific merit, investigator qualifications, innovation, approach, and environment. Reviewers assess the likelihood that the proposed research program will establish a successful independent career and produce impactful scientific contributions. Funding decisions also consider program priorities, portfolio balance, and available funds. After peer review, applications undergo advisory council review before final award decisions are made. This funding opportunity follows a recurring submission schedule with multiple deadlines per year, including October 2, 2026; February 3, 2027; October 4, 2027; February 3, 2028; October 3, 2028; and February 6, 2029. Applications must be submitted by 5:00 PM local time on the due date. Earliest project start dates are typically several months after submission, following review and approval processes. Applicants are encouraged to contact NIGMS program officers prior to submission for guidance on project alignment and suitability.

Focus on presenting a cohesive research program rather than specific aims; demonstrate flexibility and long-term vision; ensure alignment with NIGMS mission; highlight investigator independence and potential for impact